Alembic Pharmaceuticals Limited — Important, 03-07-2025: Updates

Alembic Pharmaceuticals has announced a board meeting to approve the financial results for the quarter and half-year. Its wholly owned US subsidiary, Alembic Pharmaceuticals Inc., has acquired 100% of Utility Therapeutics Ltd., a US-based firm focused on FDA-approved and pipeline products for urinary tract infections. The deal involves approx. $12mn in cash paid in stages linked to milestones, plus future profit sharing. This acquisition enhances Alembic’s US portfolio in niche branded therapies, potentially boosting its pharma franchise in the American market.